These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2918768)

  • 1. Government viewpoint of clinical trials of cardiovascular drugs.
    Temple R
    Med Clin North Am; 1989 Mar; 73(2):495-509. PubMed ID: 2918768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the FDA Amendment Act with trial registration, publication, and outcome reporting.
    Phillips AT; Desai NR; Krumholz HM; Zou CX; Miller JE; Ross JS
    Trials; 2017 Jul; 18(1):333. PubMed ID: 28720112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lessons from overviews of cardiovascular trials.
    Furberg CD; Morgan TM
    Stat Med; 1987; 6(3):295-306. PubMed ID: 3616285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scientific misconduct in investigational drug trials.
    Shapiro MF; Charrow RP
    N Engl J Med; 1985 Mar; 312(11):731-6. PubMed ID: 3974649
    [No Abstract]   [Full Text] [Related]  

  • 5. An FDA Viewpoint on Unique Considerations for Medical-Device Clinical Trials.
    Faris O; Shuren J
    N Engl J Med; 2017 Apr; 376(14):1350-1357. PubMed ID: 28379790
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical drug trials in Alzheimer disease. What are some of the issues?
    Jarvik LF; Berg L; Bartus R; Heston L; Leith N; Phelps C; Shader R; Whitehouse P
    Alzheimer Dis Assoc Disord; 1990; 4(4):193-202. PubMed ID: 2264978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What conditions are necessary to assess antidepressant efficacy?
    Quitkin FM; Klein DF
    Arch Gen Psychiatry; 2000 Apr; 57(4):323-4. PubMed ID: 10768690
    [No Abstract]   [Full Text] [Related]  

  • 8. Transforming Drug Development in Heart Failure: Navigating the Regulatory Crossroads.
    Vaduganathan M; Butler J; Gheorghiade M
    Circ Heart Fail; 2016 Oct; 9(10):. PubMed ID: 27707750
    [No Abstract]   [Full Text] [Related]  

  • 9. Ethics of private panels comes under scrutiny.
    Wadman M
    Nature; 1997 May; 387(6632):445. PubMed ID: 9168099
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of the FDA in cancer therapy research.
    Young RS
    Semin Oncol; 1981 Dec; 8(4):447-52. PubMed ID: 7323818
    [No Abstract]   [Full Text] [Related]  

  • 11. Dose-ranging in clinical trials: rationale and proposed use with placebo or positive controls.
    Freston JW
    Am J Gastroenterol; 1986 May; 81(5):307-11. PubMed ID: 3706243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethical problems arise over clinical trials on new drugs.
    Hosp Ethics; 1992; 8(5):12-3. PubMed ID: 10120132
    [No Abstract]   [Full Text] [Related]  

  • 13. Consider drug efficacy before first-in-human trials.
    Kimmelman J; Federico C
    Nature; 2017 Jan; 542(7639):25-27. PubMed ID: 28150789
    [No Abstract]   [Full Text] [Related]  

  • 14. Regulatory and scientific issues regarding use of foreign data in support of new drug applications in the United States: an FDA perspective.
    Khin NA; Yang P; Hung HM; Maung-U K; Chen YF; Meeker-O'Connell A; Okwesili P; Yasuda SU; Ball LK; Huang SM; O'Neill RT; Temple R
    Clin Pharmacol Ther; 2013 Aug; 94(2):230-42. PubMed ID: 23588316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of the Drug Trials Snapshots Program of the US Food and Drug Administration: Women in Cardiovascular Drug Trials.
    Whyte J; Woodcock J; Wang J
    JAMA Intern Med; 2017 May; 177(5):724-727. PubMed ID: 28288256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Making clinical trials safer for human subjects.
    Baram M
    Am J Law Med; 2001; 27(2-3):253-82. PubMed ID: 11467112
    [No Abstract]   [Full Text] [Related]  

  • 17. General guidelines for the clinical evaluation of anti-infective drug products. Infectious Diseases Society of America and the Food and Drug Administration.
    Beam TR; Gilbert DN; Kunin CM
    Clin Infect Dis; 1992 Nov; 15 Suppl 1():S5-32. PubMed ID: 1477251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer clinical trials: what is the impact of regulatory changes?
    Kearsey L
    ONS News; 2002 Sep; 17(9):1, 4-5. PubMed ID: 12244866
    [No Abstract]   [Full Text] [Related]  

  • 19. Reassessing Phase II Heart Failure Clinical Trials: Consensus Recommendations.
    Butler J; Hamo CE; Udelson JE; O'Connor C; Sabbah HN; Metra M; Shah SJ; Kitzman DW; Teerlink JR; Bernstein HS; Brooks G; Depre C; DeSouza MM; Dinh W; Donovan M; Frische-Danielson R; Frost RJ; Garza D; Gohring UM; Hellawell J; Hsia J; Ishihara S; Kay-Mugford P; Koglin J; Kozinn M; Larson CJ; Mayo M; Gan LM; Mugnier P; Mushonga S; Roessig L; Russo C; Salsali A; Satler C; Shi V; Ticho B; van der Laan M; Yancy C; Stockbridge N; Gheorghiade M
    Circ Heart Fail; 2017 Apr; 10(4):. PubMed ID: 28356300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDA oversight of cell therapy clinical trials.
    Au P; Hursh DA; Lim A; Moos MC; Oh SS; Schneider BS; Witten CM
    Sci Transl Med; 2012 Aug; 4(149):149fs31. PubMed ID: 22932219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.